Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.74NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
B.1.1.74NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-1125.12Thailand
B.1.1.74NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3277.98Thailand
B.1.1.74NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-1491.05US
B.1.1.74NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-1638.08US
B.1.1.74NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-54.8415US
B.1.1.74NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
B.1.1.74NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-2071.98US
B.1.1.74NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-6093.96US
B.1.1.74NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-1648.07Singapore
B.1.1.74NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
B.1.1.74NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-5467.16Germany
B.1.1.74NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-5544.17Germany
B.1.1.74NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-6431.9South Korea
B.1.1.74NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.1.74NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-2601.1Japan
B.1.1.74NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-4177.83Japan
B.1.1.74NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-893.215Hong Kong
B.1.1.74NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-1591.5Hong Kong
B.1.1.74NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
B.1.1.74NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-5132.63China
B.1.1.74NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-3888.18US
B.1.1.74NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
B.1.1.74ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-1885.04Japan
B.1.1.74ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-25657.5Japan
B.1.1.74ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-1981.59Japan
B.1.1.74ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-21257.9Japan
B.1.1.74ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-2648.21Japan
B.1.1.74ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
B.1.1.74SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
B.1.1.74SWuhanCoV-spk1TGTGGTTCATAAAAATTCCTTTGTG25322490024876R-23857.7Japan
B.1.1.74SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-20966Japan
B.1.1.74SNIID WH-1 F24381R24873ATTTGAAACAAAGACACCTTCAC2334.782485624834R-22193.2Japan
B.1.1.74SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-21400.8Japan
B.1.1.74SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-20677.6Japan
B.1.1.72ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
B.1.1.72ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
B.1.1.72ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
B.1.1.72ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
B.1.1.72ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
B.1.1.72ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.72ORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-20516.2China
B.1.1.72ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
B.1.1.72ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
B.1.1.72ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
B.1.1.72ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
B.1.1.72ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
B.1.1.72ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.1.72ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.72ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used